Organogenesis Holdings Inc. (ORGO)
Nasdaq: ORGO · Pharmaceutical Preparations · Canton, MA · filing with the SEC since 2015
Grade5.9
◀ Past 5.5● Present 7.0▶ Future 4.8
Who owns Organogenesis Holdings Inc.
As filed with the SECHolders of 5% or more
3
Alan A. Ades holds 17.6% of Class A Common Stock, par value $0.0001 per share, as its SCHEDULE 13D/A filed Jun 26, 2025 says.
Directors and officers
16
report now, of 40 people on the record since 2016. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Alan A. Ades
SCHEDULE 13D/A · filed Jun 26, 2025 · Class A Common Stock, par value $0.0001 per share · 17.8% in Jan 13, 2025
Glenn H. Nussdorf
SCHEDULE 13D/A · filed Nov 3, 2025 · Class A Common Stock, par value $0.0001 per share
Soleus Capital Master Fund, L.P.
SCHEDULE 13G/A · filed Feb 12, 2026 · Common Stock, $0.0001 par value per share · 9.9% in Feb 11, 2025
Mathew P. Arens
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, $0.01 par value · reported falling below 5%, from 6.55% in Aug 14, 2025
What ORGO reports owning in othersstakes of 5% or more, and other ties
3 subsidiaries in 2 countries, from the list filed with the 10-K filed Feb 26, 2026.
Insider tradesForm 4
4sales
2purchases
0sales on a scheduled plan
1people selling
$2.6Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 56 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Nussdorf Glenn H | director | 4 | $2.6M | 0 | 0 | $0 |
| Driscoll Michael Joseph | director | 0 | $0 | 0 | 1 | $0 |
| Leibowitz Arthur S | director | 0 | $0 | 0 | 1 | $0 |